drugset
drugset / Trial / NCT01544361

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

NCT01544361 ↗

Phase 1 Completed 125 enrolled MedImmune LLC
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 1 study to evaluate the safety and tolerability of single ascending intravenous doses of MEDI7814 in healthy adult subjects.

Timeline

Start
2012-01
Primary completion
2012-09
Completion
2012-09

Drugs

EvaluationDrugModalityDoseRoute
Subject MEDI7814 Unknown 1 mg/kg Intravenous
Subject MEDI7814 Unknown 3 mg/kg Intravenous
Subject MEDI7814 Unknown 10 mg/kg Intravenous
Subject MEDI7814 Unknown 20 mg/kg Intravenous

Indications

No indication recorded.